ALGN
Price
$189.03
Change
-$1.74 (-0.91%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
24.63B
9 days until earnings call
BNGO
Price
$3.48
Change
+$0.05 (+1.46%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
57.43M
Interact to see
Advertisement

ALGN vs BNGO

Header iconALGN vs BNGO Comparison
Open Charts ALGN vs BNGOBanner chart's image
Align Technology
Price$189.03
Change-$1.74 (-0.91%)
Volume$6.41K
Capitalization24.63B
Bionano Genomics
Price$3.48
Change+$0.05 (+1.46%)
Volume$300
Capitalization57.43M
ALGN vs BNGO Comparison Chart in %
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. BNGO commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Hold and BNGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (ALGN: $190.77 vs. BNGO: $3.43)
Brand notoriety: ALGN: Notable vs. BNGO: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ALGN: 57% vs. BNGO: 65%
Market capitalization -- ALGN: $24.63B vs. BNGO: $57.43M
ALGN [@Medical Specialties] is valued at $24.63B. BNGO’s [@Medical Specialties] market capitalization is $57.43M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileBNGO’s FA Score has 1 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • BNGO’s FA Score: 1 green, 4 red.
According to our system of comparison, BNGO is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 4 TA indicator(s) are bullish while BNGO’s TA Score has 5 bullish TA indicator(s).

  • ALGN’s TA Score: 4 bullish, 5 bearish.
  • BNGO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BNGO is a better buy in the short-term than ALGN.

Price Growth

ALGN (@Medical Specialties) experienced а -5.69% price change this week, while BNGO (@Medical Specialties) price change was +0.88% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.54%. For the same industry, the average monthly price growth was +3.32%, and the average quarterly price growth was -2.57%.

Reported Earning Dates

ALGN is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+0.54% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($24.6B) has a higher market cap than BNGO($57.4M). ALGN YTD gains are higher at: -8.508 vs. BNGO (-80.178). ALGN has higher annual earnings (EBITDA): 799M vs. BNGO (-213.4M). ALGN has more cash in the bank: 973M vs. BNGO (102M). BNGO has less debt than ALGN: BNGO (79.4M) vs ALGN (127M). ALGN has higher revenues than BNGO: ALGN (3.86B) vs BNGO (36.1M).
ALGNBNGOALGN / BNGO
Capitalization24.6B57.4M42,857%
EBITDA799M-213.4M-374%
Gain YTD-8.508-80.17811%
P/E Ratio55.01N/A-
Revenue3.86B36.1M10,698%
Total Cash973M102M954%
Total Debt127M79.4M160%
FUNDAMENTALS RATINGS
ALGN vs BNGO: Fundamental Ratings
ALGN
BNGO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6598
PRICE GROWTH RATING
1..100
5865
P/E GROWTH RATING
1..100
7289
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNGO's Valuation (26) in the Biotechnology industry is somewhat better than the same rating for ALGN (76) in the Medical Specialties industry. This means that BNGO’s stock grew somewhat faster than ALGN’s over the last 12 months.

BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALGN (100) in the Medical Specialties industry. This means that BNGO’s stock grew similarly to ALGN’s over the last 12 months.

ALGN's SMR Rating (65) in the Medical Specialties industry is somewhat better than the same rating for BNGO (98) in the Biotechnology industry. This means that ALGN’s stock grew somewhat faster than BNGO’s over the last 12 months.

ALGN's Price Growth Rating (58) in the Medical Specialties industry is in the same range as BNGO (65) in the Biotechnology industry. This means that ALGN’s stock grew similarly to BNGO’s over the last 12 months.

ALGN's P/E Growth Rating (72) in the Medical Specialties industry is in the same range as BNGO (89) in the Biotechnology industry. This means that ALGN’s stock grew similarly to BNGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNBNGO
RSI
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
Bearish Trend 4 days ago
67%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
74%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
70%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PGJ29.990.17
+0.57%
Invesco Golden Dragon China ETF
IFEB28.490.02
+0.06%
Innovator Intl Dev Pwr Bffr ETF - Feb
SIXH38.48N/A
N/A
ETC 6 Meridian Hdg Eq-Idx Opt Strat ETF
BUFP28.30-0.02
-0.07%
PGIM Laddered S&P 500 Buffer 12 ETF
ESGE39.92-0.10
-0.25%
iShares ESG Aware MSCI EM ETF

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been loosely correlated with JNDOF. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGN jumps, then JNDOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
-0.78%
JNDOF - ALGN
60%
Loosely correlated
N/A
NVST - ALGN
52%
Loosely correlated
-1.22%
ITGR - ALGN
44%
Loosely correlated
-1.88%
ARAY - ALGN
42%
Loosely correlated
-1.84%
TWST - ALGN
41%
Loosely correlated
-1.90%
More

BNGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNGO has been loosely correlated with ALGN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BNGO jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNGO
1D Price
Change %
BNGO100%
+0.88%
ALGN - BNGO
35%
Loosely correlated
-0.78%
MBOT - BNGO
34%
Loosely correlated
-1.98%
PACB - BNGO
31%
Poorly correlated
-1.44%
ARAY - BNGO
31%
Poorly correlated
-1.84%
MDT - BNGO
30%
Poorly correlated
+0.09%
More